Production (Stage)
BioELife Corp.
LITH
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | 54.43% | -232.25% | 115.58% | -1,467.11% | -80.25% |
| Total Depreciation and Amortization | 300.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -75.00% | -56.92% | -64.67% |
| Total Other Non-Cash Items | -50.88% | 169.89% | -123.56% | 811.93% | 71.11% |
| Change in Net Operating Assets | -2,966.67% | 40.00% | -114.29% | 84.21% | -13.64% |
| Cash from Operations | -32.10% | 21.22% | -83.96% | -3.89% | 5.76% |
| Capital Expenditure | 35.19% | -68.75% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.76% | -42.11% | 18,266.67% | -- | -- |
| Cash from Investing | 11.70% | -48.94% | 17,200.00% | 150.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -933.33% | -103.43% | 195.11% | 1.08% | 2.62% |